間葉系幹細胞の世界市場レポート 2025年

間葉系幹細胞市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は12.6％で、61億4,000万米ドルに成長します。予測期間の成長は、遺伝子工学技術の継続的な進歩、個別化医療アプローチの採用、人工知能（AI）とデータ分析の統合、生体材料科学と3Dバイオプリンティング技術の進歩、マイクロ流体デバイスと臓器オンチップモデルの開発、次世代製造技術の採用に起因すると考えられます。予測期間における主な動向としては、バイオプリンティングと組織工学、遺伝子編集、臨床応用の拡大、併用療法、MSC由来細胞外小胞（EV）などが挙げられます。

再生医療に対する意識の高まりが、今後の間葉系幹細胞（MSC）市場の成長を牽引すると予想されます。再生医療は、先天的欠陥、疾患、外傷、加齢などの原因によって損なわれた機能を回復させるために、細胞、組織、または臓器を修復、置換、または再生することに焦点を当てた学際的な新興分野です。再生医療の成長には、臨床試験の増加、慢性疾患や加齢に関連する疾患の有病率の増加、個別化医療の進展などの主な要因があります。間葉系幹細胞（MSCs）は、様々な細胞型に分化し、免疫応答を調節し、多くの病状において組織の修復と再生を促進する能力を持つため、再生医療において大きな期待を集めています。例えば、米国を拠点とする非営利団体Alliance for Regenerative Medicineは、2023年8月に、2023年第1四半期における細胞・遺伝子・組織工学の治療開発者は世界全体で2,760人であり、2022年第1四半期の1,369人から101％増加したと報告しました。さらに、米国遺伝子・細胞治療学会（ASGCT）とCitelineが2023年7月に発表した報告書によると、2023年第1四半期末時点でフェーズII段階にある遺伝子治療薬は247件で、2023年第2四半期末時点では5％増の260件となっています。その結果、再生医療に対する意識の高まりが間葉系幹細胞（MSC）市場の拡大に寄与しています。

間葉系幹細胞（MSCs）市場の主要企業は、GMP準拠の分離などの革新的技術を活用して市場での存在感を高めています。GMP準拠の分離とは、一貫した生産と品質管理を保証するために、適正製造基準（GMP）規制に従ってMSCを含む細胞を分離することです。例えば、プロモセルは最近、GMP規制環境下でのヒトMSCの増殖用に特別に調合された血清・ゼノフリー培地であるプロモエクスキューMSC増殖培地XFを発表しました。この培地は、最高の品質基準に準拠し、EXCiPACT GMP認証を受けており、骨髄、臍帯マトリックス、脂肪組織などの様々な起源から供給されたMSCの一貫した増殖と維持を容易にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界間葉系幹細胞 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の間葉系幹細胞市場：成長率分析
• 世界の間葉系幹細胞市場の実績：規模と成長, 2019-2024
• 世界の間葉系幹細胞市場の予測：規模と成長, 2024-2029, 2034F
• 世界間葉系幹細胞総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の間葉系幹細胞市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家移植
• 同種異系
• 世界の間葉系幹細胞市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞と細胞株
• キット、培地、試薬
• その他の製品タイプ
• 世界の間葉系幹細胞市場ワークフロータイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞の調達と分離
• 培養と凍結保存
• 差別化
• キャラクター設定
• 世界の間葉系幹細胞市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨と軟骨の修復
• 心血管疾患
• 炎症性および免疫疾患
• 肝臓疾患
• がん
• GVHD
• その他の適応症
• 世界の間葉系幹細胞市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疾患モデル
• 医薬品の開発と発見
• 幹細胞バンキング
• 組織工学
• 毒性学研究
• その他の用途
• 世界の間葉系幹細胞市場、自家移植のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨髄由来
• 脂肪組織由来
• 臍帯血由来
• 末梢血由来
• 世界の間葉系幹細胞市場、同種異系疾患のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨髄由来
• 臍帯由来
• 胎盤由来
• 人工多能性幹細胞（iPSC）由来
• ウォートンのゼリー由来

第7章 地域別・国別分析

• 世界の間葉系幹細胞市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の間葉系幹細胞市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 間葉系幹細胞市場：競合情勢
• 間葉系幹細胞市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson, and Company Overview, Products and Services, Strategy and Financial Analysis
  • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Corning Inc.
• Daiichi Sankyo
• Lonza Group
• Terumo Corporation
• Sartorius AG
• Getinge AB
• Bio-Rad Laboratories
• Eppendorf AG
• Bio-Techne Corporation
• STEMCELL Technologies Inc.
• Miltenyi Biotec GmbH
• Takara Bio Group
• Organogenesis Holdings Inc.
• Vericel Corporation
• HiMedia Laboratories

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 間葉系幹細胞市場2029：新たな機会を提供する国
• 間葉系幹細胞市場2029：新たな機会を提供するセグメント
• 間葉系幹細胞市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Mesenchymal stem cells (MSCs) represent a type of multipotent adult stem cells distributed across various tissues in the body, including bone marrow, adipose tissue, umbilical cord blood, and dental pulp. These cells possess the capacity to differentiate into diverse cell types, including osteoblasts (bone cells) and chondrocytes (cartilage cells), rendering them valuable in treating various conditions such as bone and cartilage repair, myocardial infarction, and neurological disorders.

The primary types of mesenchymal stem cells are autologous and allogeneic. Autologous pertains to medical procedures where cells, tissues, or substances are obtained from an individual and then reintroduced into the same individual. Various product types are available, including cells and cell lines, kits, media and reagents, among others, along with different workflow types such as cell sourcing and isolation, culture and cryopreservation, differentiation, and characterization. These are utilized for several indications, including bone and cartilage repair, cardiovascular diseases, inflammatory and immunological diseases, liver diseases, cancer, GvHD, among others, and across various applications such as disease modeling, drug development and discovery, stem cell banking, tissue engineering, and toxicology studies.

The mesenchymal stem cells market research report is one of a series of new reports from The Business Research Company that provides mesenchymal stem cells market statistics, including mesenchymal stem cells industry global market size, regional shares, competitors with a mesenchymal stem cells market share, detailed mesenchymal stem cells market segments, market trends, and opportunities, and any further data you may need to thrive in the mesenchymal stem cells industry. This mesenchymal stem cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry

The mesenchymal stem cells market size has grown rapidly in recent years. It will grow from $3.38 billion in 2024 to $3.82 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to the regenerative medicine paradigm shift, collaborative research efforts, increased public awareness of stem cell research and patient advocacy, international collaboration, and standardization initiatives.

The mesenchymal stem cells market size is expected to see rapid growth in the next few years. It will grow to $6.14 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to continued advancements in genetic engineering technologies, the adoption of personalized medicine approaches, the integration of artificial intelligence (AI) and data analytics, advances in biomaterials science and 3D bioprinting technologies, the development of microfluidic devices and organ-on-a-chip models, the adoption of next-generation manufacturing technologies. Major trends in the forecast period include bioprinting and tissue engineering, gene editing, clinical application expansion, combination therapies, and MSC-derived extracellular vesicles (EVs).

The increasing awareness of regenerative medicine is expected to drive the growth of the mesenchymal stem cells (MSC) market in the future. Regenerative medicine is an emerging, interdisciplinary field focused on repairing, replacing, or regenerating cells, tissues, or organs to restore function impaired by causes such as congenital defects, disease, trauma, and aging. The growth of regenerative medicine is fueled by key factors including the rise in clinical trials, the increasing prevalence of chronic and age-related conditions, and advancements in personalized medicine. Mesenchymal stem cells (MSCs) hold significant promise in regenerative medicine due to their ability to differentiate into various cell types, modulate immune responses, and promote tissue repair and regeneration across numerous medical conditions. For example, in August 2023, the Alliance for Regenerative Medicine, a US-based non-profit organization, reported that there were 2,760 therapeutic developers in cell, gene, and tissue engineering globally in Q1 2023, marking a 101% increase from 1,369 in Q1 2022. Additionally, a report from the American Society of Gene & Cell Therapy (ASGCT) and Citeline in July 2023 noted that at the end of Q1 2023, there were 247 gene therapies in Phase II, which rose by 5% to 260 by the end of Q2 2023. As a result, the growing awareness of regenerative medicine is contributing to the expansion of the mesenchymal stem cell (MSC) market.

Leading companies in the mesenchymal stem cells (MSCs) market are leveraging innovative technologies, such as GMP-compliant isolation, to enhance their market presence. GMP-compliant isolation involves isolating cells, including MSCs, in accordance with Good Manufacturing Practice regulations to ensure consistent production and quality control. For example, PromoCell recently introduced PromoExQ MSC Growth Medium XF, a serum- and xeno-free medium specifically formulated for the expansion of human MSCs in GMP-regulated environments. This medium adheres to the highest quality standards and is EXCiPACT GMP-certified, facilitating consistent growth and maintenance of MSCs sourced from various origins such as bone marrow, umbilical cord matrix, and adipose tissue.

In May 2024, BioSolution Designs (BSD), a US-based biotechnology innovation studio, entered into a partnership with RoosterBio, Inc. The collaboration aims to streamline the development and production of engineered human mesenchymal stem/stromal cell (MSC)-derived therapies and exosome-based therapies by combining BSD's multigenic design platform with RoosterBio's expertise in cell processing and scalable manufacturing. The partnership's goal is to accelerate the clinical progress of next-generation cell therapies. RoosterBio, Inc. is a US-based company specializing in the development of adult human mesenchymal stem/stromal cells (hMSCs).

Major companies operating in the mesenchymal stem cells market are Thermo Fischer Scientific Inc., Danaher Corporation, Merck KgaA, Becton, Dickinson, and Company, Fujifilm Holdings Corporation, Corning Inc., Daiichi Sankyo, Lonza Group, Terumo Corporation, Sartorius AG, Getinge AB, Bio-Rad Laboratories, Eppendorf AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmBH, Takara Bio Group, Organogenesis Holdings Inc., Vericel Corporation, HiMedia Laboratories, PromoCell GmbH, CellGenix GmBH, Anterogen Co. Ltd., Pluristem Therapeutics Inc., American Cryostem Corporation

North America was the largest region in the mesenchymal stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mesenchymal stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mesenchymal stem cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mesenchymal stem cells market consists of revenues earned by entities by providing services such as cell isolation and culture techniques, cryopreservation and storage, custom cell development, and MSC-based therapeutics development. The market value includes the value of related goods sold by the service provider or included within the service offering. The mesenchymal stem cells market also includes sales of MSC differentiation inducers, scaffolds and matrices, MSC-derived exosomes, and cryopreservation agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mesenchymal Stem Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mesenchymal stem cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mesenchymal stem cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mesenchymal stem cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Autologous; Allogeneic
• 2) By Product Type: Cells And Cell Lines; Kits, Media And Reagents; Other Product Types
• 3) By Workflow Type: Cell Sourcing And Isolation; Culture And Cryopreservation; Differentiation; Characterization
• 4) By Indication: Bone And Cartilage Repair; Cardiovascular Diseases; Inflammatory And Immunological Diseases; Liver Diseases; Cancer; GvHD; Other Indications
• 5) By Application: Disease Modeling; Drug Development And Discovery; Stem Cell Banking; Tissue Engineering; Toxicology Studies; Other Applications
• Subsegments:
• 1) By Autologous: Bone Marrow-Derived; Adipose Tissue-Derived; Cord Blood-Derived; Peripheral Blood-Derived
• 2) By Allogeneic: Bone Marrow-Derived; Umbilical Cord-Derived; Placental-Derived; Induced Pluripotent Stem Cells (iPSCs) Derived; Wharton's Jelly-Derived
• Companies Mentioned: Thermo Fischer Scientific Inc.; Danaher Corporation; Merck KgaA; Becton, Dickinson, and Company; Fujifilm Holdings Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mesenchymal Stem Cells Market Characteristics

3. Mesenchymal Stem Cells Market Trends And Strategies

4. Mesenchymal Stem Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Mesenchymal Stem Cells Growth Analysis And Strategic Analysis Framework

• 5.1. Global Mesenchymal Stem Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Mesenchymal Stem Cells Market Growth Rate Analysis
• 5.4. Global Mesenchymal Stem Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Mesenchymal Stem Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Mesenchymal Stem Cells Total Addressable Market (TAM)

6. Mesenchymal Stem Cells Market Segmentation

• 6.1. Global Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous
• Allogeneic
• 6.2. Global Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cells And Cell Lines
• Kits, Media And Reagents
• Other Product Types
• 6.3. Global Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Sourcing And Isolation
• Culture And Cryopreservation
• Differentiation
• Characterization
• 6.4. Global Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone And Cartilage Repair
• Cardiovascular Diseases
• Inflammatory And Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Other Indications
• 6.5. Global Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Modeling
• Drug Development And Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Other Applications
• 6.6. Global Mesenchymal Stem Cells Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow-Derived
• Adipose Tissue-Derived
• Cord Blood-Derived
• Peripheral Blood-Derived
• 6.7. Global Mesenchymal Stem Cells Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow-Derived
• Umbilical Cord-Derived
• Placental-Derived
• Induced Pluripotent Stem Cells (iPSCs) Derived
• Wharton's Jelly-Derived

7. Mesenchymal Stem Cells Market Regional And Country Analysis

• 7.1. Global Mesenchymal Stem Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Mesenchymal Stem Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mesenchymal Stem Cells Market

• 8.1. Asia-Pacific Mesenchymal Stem Cells Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mesenchymal Stem Cells Market

• 9.1. China Mesenchymal Stem Cells Market Overview
• 9.2. China Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mesenchymal Stem Cells Market

• 10.1. India Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mesenchymal Stem Cells Market

• 11.1. Japan Mesenchymal Stem Cells Market Overview
• 11.2. Japan Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mesenchymal Stem Cells Market

• 12.1. Australia Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mesenchymal Stem Cells Market

• 13.1. Indonesia Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mesenchymal Stem Cells Market

• 14.1. South Korea Mesenchymal Stem Cells Market Overview
• 14.2. South Korea Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mesenchymal Stem Cells Market

• 15.1. Western Europe Mesenchymal Stem Cells Market Overview
• 15.2. Western Europe Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mesenchymal Stem Cells Market

• 16.1. UK Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mesenchymal Stem Cells Market

• 17.1. Germany Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mesenchymal Stem Cells Market

• 18.1. France Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mesenchymal Stem Cells Market

• 19.1. Italy Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mesenchymal Stem Cells Market

• 20.1. Spain Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mesenchymal Stem Cells Market

• 21.1. Eastern Europe Mesenchymal Stem Cells Market Overview
• 21.2. Eastern Europe Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mesenchymal Stem Cells Market

• 22.1. Russia Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mesenchymal Stem Cells Market

• 23.1. North America Mesenchymal Stem Cells Market Overview
• 23.2. North America Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mesenchymal Stem Cells Market

• 24.1. USA Mesenchymal Stem Cells Market Overview
• 24.2. USA Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mesenchymal Stem Cells Market

• 25.1. Canada Mesenchymal Stem Cells Market Overview
• 25.2. Canada Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mesenchymal Stem Cells Market

• 26.1. South America Mesenchymal Stem Cells Market Overview
• 26.2. South America Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mesenchymal Stem Cells Market

• 27.1. Brazil Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mesenchymal Stem Cells Market

• 28.1. Middle East Mesenchymal Stem Cells Market Overview
• 28.2. Middle East Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mesenchymal Stem Cells Market

• 29.1. Africa Mesenchymal Stem Cells Market Overview
• 29.2. Africa Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mesenchymal Stem Cells Market Competitive Landscape And Company Profiles

• 30.1. Mesenchymal Stem Cells Market Competitive Landscape
• 30.2. Mesenchymal Stem Cells Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton, Dickinson, and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Mesenchymal Stem Cells Market Other Major And Innovative Companies

• 31.1. Corning Inc.
• 31.2. Daiichi Sankyo
• 31.3. Lonza Group
• 31.4. Terumo Corporation
• 31.5. Sartorius AG
• 31.6. Getinge AB
• 31.7. Bio-Rad Laboratories
• 31.8. Eppendorf AG
• 31.9. Bio-Techne Corporation
• 31.10. STEMCELL Technologies Inc.
• 31.11. Miltenyi Biotec GmbH
• 31.12. Takara Bio Group
• 31.13. Organogenesis Holdings Inc.
• 31.14. Vericel Corporation
• 31.15. HiMedia Laboratories

32. Global Mesenchymal Stem Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mesenchymal Stem Cells Market

34. Recent Developments In The Mesenchymal Stem Cells Market

35. Mesenchymal Stem Cells Market High Potential Countries, Segments and Strategies

• 35.1 Mesenchymal Stem Cells Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Mesenchymal Stem Cells Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Mesenchymal Stem Cells Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer